You are here: Industry Insights > CDMO

News List

CMAB Bolsters Executive Team contractpharma
April 06, 2020
CMAB Biopharma (Suzhou) Inc., a biologics contract manufacturing and development organization (CDMO), has appointed Ye Shi as the head of quality.
CMAB Biopharma Resumes Full-Scale Operation contractpharma
March 25, 2020
CMAB Biopharma has reported that its facility in Suzhou, China has now resumed full operation following the coronavirus COVID-19 outbreak.
Fujifilm Invests $83M to Expand Microbial Capacity contractpharma
March 23, 2020
Fujifilm Corporation has unveiled plans to invest approximately $83 million to expand the microbial production capacity of Fujifilm Diosynth Biotechnologies (FDB).
Chime Biologics Supports COVID-19 Outbreak in Wuhan contractpharma
March 13, 2020
Chime Biologics, a China-based contract development and manufacturing organization (CDMO) providing fully-integrated services to support development and manufacturing of complex biologic ...
Evolving World of Pharma: Spray Drying In the Pharma Industry Sarah Harding
March 04, 2020
Investments in technology are – quite rightly – frequently seen to be a strong rationale for press releases from industry players, especially those in the contract manufacturing business.
Joinn Biologics nabs $60M to use for biologics capacity fiercepharma
December 20, 2019
A Chinese-American CDMO has raised $60 million but doesn’t intend to hold onto the cash very long. Joinn Biologics says it will use most of it to build a plant to increase its biologics production ...
Vetter's Occupational Health Management Excels Again in Employee Wellness Initiatives b3cnewswire
December 18, 2019
According to studies, an ever-greater number of staff members are complaining about increasing mental stress. Nevertheless ...
Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO En-CPhI.CN
November 15, 2019
Samsung Biologics announced that it has obtained ISO 27001 certification, the most prestigious international standard on information security management.
CMAB Biopharma and BJ Bioscience Establish an Exclusive Strategic Partnership En-CPhI.CN
October 12, 2019
CMAB Biopharma (Suzhou) Inc. ("CMAB"), a pure-play biologics CDMO and BJ Bioscience Inc. ("BJ Bioscience"), an innovative biopharmaceutical enterprise ...
Mallinckrodt to Sell CDMO BioVectra for $250M contractpharma
September 12, 2019
BioVectra will continue to supply an API for Mallinckrodt's specialty brands business under a long-term deal.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page